Genetic mechanisms that underlie epilepsy

Nature Reviews Neuroscience

Volumn 5, Issue 5, 2004, Pages 400-408

  Steinlein, Ortrud K ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CHLORIDE CHANNEL; CYSTEINE PROTEINASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; GLUCOSE POLYMER; NICOTINIC RECEPTOR; POTASSIUM CHANNEL; SODIUM CHANNEL;

BRAIN DEVELOPMENT; BRAIN MITOCHONDRION; CELL COMMUNICATION; CELL METABOLISM; EPILEPSY; EPILEPTOGENESIS; FRONTAL LOBE EPILEPSY; GENE; GENE FUNCTION; GENE MUTATION; HAPPY PUPPET SYNDROME; HEREDITY; HUMAN; INHERITANCE; LIPIDOSIS; NERVE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY CHAIN; REVIEW; THOMSEN DISEASE;

EID: 2342598414     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1388     Document Type: Review

References (77)

1. Steinlein, O. et al. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genet. 11, 201-203 (1995). This paper described the Identification of the first gene that was found to be responsible for idiopathic epilepsy in humans.
2. Fusco, M. D. et al. The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nature Genet. 26, 275-276 (2000).
3. Biervert, C. et al. A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406 (1998).
4. Singh, N. A. et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nature Genet. 18, 25-29 (1998).
5. Charlier, C. et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nature Genet. 18, 53-55 (1998).
6. +-channel β1 subunit gene SCN1B. Nature Genet. 19, 366-370 (1998).
7. Escayg, A. et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nature Genet. 24, 343-345 (2000).
8. v1.2 in a patient with febdle and afebrile seizures causes channel dysfunction. Proc. Natl. Acad. Sci. USA 98, 6384-6389 (2001).
9. A receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene. Nature Genet. 28, 46-48 (2001).
10. A receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nature Genet. 28, 49-52 (2001).
11. Kalachikov, S. et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nature Genet. 30, 335-341 (2002). The LGI1 gene described in this paper was the first non-ion channel gene to be implicated in human idiopathic epilepsy.
12. Heron, S. E. et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 360, 851-852 (2002).
13. Nakayama, J. et al. A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures. Ann. Neurol. 52, 654-657 (2002).
14. Cossette, P. et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nature Genet. 31, 184-189 (2002).
15. Haug, K. et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nature Genet. 33, 527-532 (2003).
16. Phillips, H. A. et al. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q13.2. Nature Genet. 10, 117-118 (1995).
17. Hayman, M., Scheffer, I. E., Chinvarun, Y., Berlangieri, S. U. & Berkovic, S. F. Autosomal dominant nocturnal frontal lobe epilepsy: demonstration of focal frontal onset and intrafamilial variation. Neurology 49, 969-975 (1997).
18. Scheffer, I. E. & Berkovic, S. F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120, 479-490 (1997).
19. Kullmann, D. M. & Hanna, M. G. Neurological disorders caused by inherited ion channel mutations. Lancet. 1, 157-166 (2002).
20. Scheffer, I. E. et al. Autosomal dominant nocturnal frontal lobe epilepsy: a distinctive clinical disorder. Brain 118, 61-73 (1995).
21. Steinlein, O. et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6, 943-947 (1997).
22. Hirose, S. et al. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 53, 1749-1753 (1999).
23. Phillips, H. A. et al. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann. Neurol. 48, 264-267 (2000).
24. Phillips, H. A. et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am. J. Hum. Genet. 68, 225-231 (2001).
25. Bertrand, D. et al. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia 43 (Suppl. 5), 112-122 (2002). The authors compare the distinct functional properties of four nAChR mutations associated with ADNFLE, and discuss their findings in the context of the latest knowledge of pyramidal cell function.
26. Magnusson, A., Stordal, E., Brodtkorb, E. & Steinlein, O. Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy. Psychiat. Genet. 13, 91-95 (2003).
27. Cho, Y.-W. et al. A korean kindred with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) presenting as partial seizures with mental retardation. Arch. Neurol. 60, 1625-1632 (2003).
28. Ronen, G. M., Rosales, T. O., Connolly, M., Anderson, V. E. & Leppert, M. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 43, 1355-1360 (1993).
29. Wakai, S. et al. Classification of familial neonatal convulsions. Lancet 344, 1376 (1994).
30. Dedek, K., Fusco, L., Teloy, N. & Steinlein, O. K. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res. 54, 21-27 (2003).
31. Wang, H. S. et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282, 1899-1893 (1998). The authors were the first to discover that the potassium channel genes associated with BFNC encode subunits of the long-known M-channel, an important modulator of neuronal excitability.
32. Brown, D. M-currents: an update. Trends Neurosci. 11, 294-299 (1988).
33. + channel. Proc. Natl. Acad. Sci. USA 98, 12272-12277 (2001).
34. Watanabe, H. et al. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J. Neurochem. 75, 28-33 (2000).
35. v 1.1 mutations cause febrile seizures associated with afebrile partial seizures. Neurology 57, 703-705 (2001).
36. A-receptor γ2 subunit in a family with generalized epilepsy with febrile seizures plus. Am. J. Hum. Genet. 70, 530-536 (2002).
37. Kananura, C. et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch. Neurol. 59, 1137-1141 (2002).
38. A receptor mutation. Brain 128, 230-240 (2003).
39. Lossin, C., Wang, D. W., Rhodes, T. H., Vanoye, C. G. & George, A. L. Molecular basis of an inherited epilepsy. Neuron 34, 877-884 (2002).
40. Spampanato, J., Escayg, A., Meisler M. H. & Goldin, A. L. Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J. Neurosci. 21, 7481-7490 (2001).
41. Lossin C. et al. Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J. Neurosci. 23, 11289-91125 (2003).
42. Claes, L. et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68, 1327-1332 (2001).
43. Winawer, M. R. et al. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 54, 2173-2176 (2000).
44. Brodtkorb, E., Gu, W., Nakken, K. O., Fischer, C. & Steinlein, O. K. Familial temporal lobe epilepsy with aphasic seizures and linkage to chromosome 10q22-q24. Epilepsia 43, 228-235 (2002).
45. Gu, W., Brodtkorb, E. & Steinlein, O. K. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann. Neurol. 52, 364-367 (2002).
46. Morante-Redolat, J. M. et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum. Mol. Genet. 11, 1119-1128 (2002).
47. Pizzuti, A. et al. Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. Ann. Neurol. 53, 396-399 (2003).
48. Fertig, E., Lincoln, A., Martinuzzi, A., Mattson, R. H. & Hisama, F. M. Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. Neurology 60, 1687-1690 (2003).
49. Gu, W. et al. The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine-rich repeat proteins. FEBS Lett. 519, 71-76 (2002).
50. Scheel, H., Tomiuk, S. & Hofmann, K. A common protein interaction domain links two recently identified epilepsy genes. Hum. Mol. Genet. 11, 1757-1762 (2002). An in silico study, which showed that LGI1 is probably not membrane-bound, end that it shares the formerly unknown epitempin repeat with another epilepsy gene, the MASS1/VLGR1 gene.
51. Staub, E. et al. The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. Trends Biochem. Sci. 27, 441-444 (2002).
52. Skradski, S. L. et al. A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron 31, 537-544 (2001).
53. Chernova, O. B., Somerville, R. P. & Cowell, J. K. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 17, 2873-2881 (1998).
54. Krex, D. et al. Physical and functional characterization of human LGI1 gene and its possible role in glioma development. Acta Neuropathol. 103, 255-266 (2002).
55. Brodtkorb, E., Nakken, K. O. & Steinlein, O. K. No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy. Epilepsy Res. 56, 205-208 (2003).
56. Berkovic, S. F., Howell, R. A., Hay, D. A. & Hopper, J. L. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann. Neurol. 43, 435-445 (1998).
57. Zara, F. et al. Mapping of genes predisposing to idiopathic generalized epilepsy. Hum. Mol. Genet. 4, 1201-1207 (1995).
58. Chioza, B. et al. Haplotype and linkage disequilibrium analysis to characterise a region in the calcium channel gene CACNA1A associated with idiopathic generalised epilepsy. Eur. J. Hum. Genet. 10, 857-864 (2002).
59. 1A calcium channel gene and common syndromes of idiopathic generalized epilepsy. Epilepsy Res. 49, 173-177 (2002).
60. Chen, Y. et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann. Neurol. 54, 239-243 (2003).
61. Sander, T. et al. Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum. Mol. Genet. 9, 1465-1472 (2000). A genome scan involving a larger number of families with common forms of idiopathic epilepsy, which led to the discovery of a mutated gene (see also reference 15).
62. Sander, T. et al. Genetic variation of the human μ-opioid receptor and susceptibility to idiopathic absence epilepsy. Epilepsy Res. 39, 57-61 (2000).
63. Wilkie, H. et al. Association of μ-opioid receptor subunit gene and idiopathic generalized epilepsy. Neurology 59, 724-728 (2002).
64. Koskiniemi, M., Donner, M., Majuri, H., Haltia, M. & Norio, R. Progressive myoclonus epilepsy. A clinical and histopathological study. Acta Neurol. Scan. 50, 307-332 (1974).
65. Haltia, M., Kristensson, K. & Sourander, P. Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol. Scan. 45, 63-77 (1969).
66. Lafreniere, R. G. et al. Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1 EPM1. Nature Genet. 15, 298-302 (1997).
67. Pennacchio, L. A. et al. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nature Genet. 20, 251-258 (1998).
68. Lieuallen, K., Pennacchio, L. A., Park, M., Myers, R. M. & Lennon, G. G. Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum. Mol. Genet. 10, 1867-1871 (2001).
69. Minassian, B. A. et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nature Genet. 20, 171-174 (1998).
70. Chan, E. M. et al. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nature Genet. 35, 125-127 (2003).
71. Fernandez-Sanchez, M. E. et al. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum. Mol. Genet. 12, 3161-3171 (2003).
72. Gleeson, J. G. et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signalling protein. Cell 92, 63-72 (1998).
73. Corbo, J. C. et al. Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. J. Neurosci. 22, 7548-7557 (2002).
74. Bai, J. et al. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nature Neurosci. 6, 1277-1283 (2003). A report that highlights the limitations of gene knockout approaches and provides new insight into the mechanisms that underlie neuronal migration during embryogenesis.
75. LYS mutation. Cell 61, 931-937 (1990).
76. Lau(UUR) gene an etiologic hot spot? J. Clin. Invest. 92, 2906-2915 (1993).
77. Feng, Y. & Walsh, C. A. Protein-protein interactions, cytoskeletal regulation and neuronal migration. Nature Rev. Neurosci. 2, 408-416 (2001).